Celcuity (CELC) Debt to Equity (2021 - 2025)

Celcuity (CELC) reported Debt to Equity of $1.26 for Q4 2025, up 48.87% on a YoY basis from $0.85 in Q4 2024, and up 17.58% quarter-over-quarter from $1.07 in Q3 2025.

Celcuity (CELC) Debt to Equity (2021 - 2025) Analysis & Trends

Celcuity has reported Debt to Equity for 5 years, with the latest figure at $1.26 in Q4 2025.

  • For the quarter ending Q4 2025, Debt to Equity rose 48.87% year-over-year to $1.26; the trailing twelve-month figure through Dec 2025 stood at $1.26 (up 48.87% YoY), and the FY2025 full-year result was $1.26, up 48.87% from the prior year.
  • Debt to Equity for Q4 2025 stood at $1.26, up from $1.07 in the prior quarter.
  • The five-year high for Debt to Equity was $2.24 in Q2 2025, with the low at $0.19 in Q3 2021.
  • Historically, Debt to Equity has averaged $0.6 across 5 years, with a median of $0.34 in 2022.
  • Annual changes were most pronounced in 2022 — Debt to Equity slumped 46.39% — and 2025, when it jumped 310.92%.
  • Celcuity's Debt to Equity stood at $0.21 in 2021, then increased by 22.86% to $0.26 in 2022, then increased by 1.32% to $0.26 in 2023, then soared by 218.99% to $0.85 in 2024, then jumped by 48.87% to $1.26 in 2025.
  • The last three Debt to Equity figures came in at $1.26 (Q4 2025), $1.07 (Q3 2025), and $2.24 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.32
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - -
7 Psyence Biomedical 227.32 Bn 227.31 Bn - -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn -
9 Abivax 91.71 Bn 91.71 Bn - -
10 Celcuity 4.14 Bn 3.42 Bn - 1.26

Historic Data

Download Data
DateValue
Dec 31, 2025 1.26
Sep 30, 2025 1.07
Jun 30, 2025 2.24
Mar 31, 2025 1.14
Dec 31, 2024 0.85
Sep 30, 2024 0.65
Jun 30, 2024 0.54
Mar 31, 2024 0.28
Dec 31, 2023 0.26
Sep 30, 2023 0.39
Jun 30, 2023 0.33
Mar 31, 2023 0.29
Dec 31, 2022 0.26
Sep 30, 2022 0.34
Jun 30, 2022 0.28
Mar 31, 2022 0.24
Dec 31, 2021 0.21
Sep 30, 2021 0.19
Jun 30, 2021 0.53